Cargando…
(Dimethylformamide-κO)(2-hydroxybenzoato-κ(2) O (1),O (1′))[tris(1-methyl-1H-benzimidazol-2-ylmethyl-κN (3))amine-κN]manganese(II) perchlorate dimethylformamide monosolvate
In the title complex, [Mn(C(7)H(5)O(3))(C(27)H(27)N(7))(C(3)H(7)NO)]ClO(4)·C(3)H(7)NO, the Mn(II) ion is coordinated in a slightly distorted monocapped trigonal-prismatic geometry. The tris(1-methyl-1H-benzimidazol-2-ylmethyl)amine (Mentb) ligand coordinates in a tetradentate mode and the coordin...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983134/ https://www.ncbi.nlm.nih.gov/pubmed/21587401 http://dx.doi.org/10.1107/S160053681003610X |
Sumario: | In the title complex, [Mn(C(7)H(5)O(3))(C(27)H(27)N(7))(C(3)H(7)NO)]ClO(4)·C(3)H(7)NO, the Mn(II) ion is coordinated in a slightly distorted monocapped trigonal-prismatic geometry. The tris(1-methyl-1H-benzimidazol-2-ylmethyl)amine (Mentb) ligand coordinates in a tetradentate mode and the coordination is completed by a bis-chelating salicylate ligand and a dimethylformamide ligand. The hydroxy group and the ortho H atoms of the salicylate ligand were refined as disordered over two sites with occupancies of 0.581 (8) and 0.419 (8). Both disorder components of the hydroxy group form intramolecular O—H⋯O hydrogen bonds. |
---|